Vioxx & Celebrex Raise Risk of First & Repeat Heart Attack: Large StudyJanuary 29th, 2007 A large study, conducted by Dr. James M. Brophy and his colleagues, from the McGill University Health Center in Montreal, confirms that selective COX2 inhibitors - Vioxx (rofecoxib) and Celebrex (celecoxib) are both associated with increased risk of repeat heart attack.
Decaffeinated Coffee May Not be Good for Your HeartNovember 21st, 2005 No, it is not a typo. However read the full article.
AIIMS to give proof of stem cell research- The Times of IndiaMarch 23rd, 2005 "Positron Emission Tomography is being installed at AIIMS next month, through which we will get the final proof of our work on heart patients. All the patients would be screened for finding how viable our work was and would also study various heart tissues of the patients metabolically," Dr P Venugopal, director AIIMS, said.
"We also plan to inject stem cells directly into the pancreatic arteries of patients suffering from diabetes," he says.
Intelligence is not a guarantee for Happy Old AgeJuly 18th, 2005 You may be a genius but that doesn't assure you of living happily when it matters most, when you are old and vulnerable than ever before. Not so intelligent people take heart.
Drug for Diabetic Nephropathy in Phase 3 TrialJuly 7th, 2005 Speedel announced today the start of its Phase III study for SPP301, its once-a-day oral endothelin A receptor antagonist (ERA) in the indication of diabetic nephropathy (diabetic kidney disease). The ASCEND(1) study has begun with the first patient visit as per the schedule outlined by Speedel in March 2005 when the company reported successful completion of the Phase II clinical trials.
Diovan (Blood Pressure Drug) Cuts Risk of Diabetes, Especially in High-Risk GroupMay 18th, 2005 Valsartan, commercially known as Diovan, a drug that controls blood pressure and reduces heart risk, also appears to protect against diabetes, especially in high-risk people, according to new research presented at the American Society of Hypertension's Twentieth Annual Scientific Meeting and Exposition (ASH 2005) by a University of Michigan physician who helped lead the study. The randomized trial involved 15,313 patients at 942 sites in 31 countries, of whom 9,995 did not have diabetes at the start of the study.
Dark Chocolate Works Like Aspirin To Prevent Heart AttacksNovember 15th, 2006 A few bits of dark chocolate a day can have the same benefit as aspirin in reducing blood clots and preventing heart attacks, researchers from Johns Hopkins University School of Medicine concluded in a study of chocolate lovers. "What these chocolate 'offenders' taught us is that the chemical in cocoa beans has a biochemical effect similar to aspirin in reducing platelet clumping which can be fatal if a clot forms and blocks a blood vessel, causing a heart attack," lead researcher Diane Becker from Johns Hopkins University School of Medicine told the annual conference of the American Heart Association, in Chicago.
Type 1 diabetics required for "ground-breaking" vision studyApril 13th, 2005 OPTOMETRY researchers at Aston University’s new £10 million Academy of Life Sciences are currently undertaking ground-breaking research into the vision problems caused by diabetics – one of the leading causes of blindness and vision loss in the UK. So far, the study has been very successful with a large number of diabetic volunteers stepping forward to take part in the study, but the researchers still require some more Type 1 diabetics (insulin dependent patients usually diagnosed under the age of 30) in order to obtain reliable results.
Research discovers response to beta-blocker therapy genetically pre-determined - must read if you are on beta-blocker therapyMay 11th, 2005 Scientists at University of Florida discovers that beta-blockers are not suitable for certain group of patients, which can be determined by their genetic makeup. In fact for this group beta-blocker therapy actually worsens the heart enlargement problem.
Study suggests "clock" gene plays a role in obesityApril 22nd, 2005 According to a study, by Fred W. Turek, Ph.D., and Joseph Bass, M.D., Ph.D., of Northwestern University in Evanston, Ill., a mutation in "Clock gene (which is responsible for circadian rhythm) also plays a role in regulating apetite and metabolism.
FDA OK's Cholesterol Drug Lipitor for DiabeticsSeptember 27th, 2005 Pfizer Inc. said U.S. regulators (FDA) have approved its cholesterol lowering drug Lipitor. Lipitor is used to reduce the risk of stroke and heart attack in diabetic patients.
Korean Study Demonstrates Feasibility of Efficiently Harvesting Genetically Identical Stem Cells from Egg DonorsMay 20th, 2005 Korean Scientists lead by Woo Suk Hwang and Shing Yong Moon of Seoul National University in Korea have successfully generated new lines of human embryonic stem cells that are exact genetic matches for individual patients, according to a new study. The researchers derived stem cells from patients with spinal cord injury, a congenital immune disorder and juvenile diabetes.
New study takes us a step closer to individualized treatmentApril 22nd, 2005 New study by 64 renowned scientists standardizes on microarray protocols. Microarrays allow scientists to see how differences in gene expression are linked to specific diseases.
TV == Idiot Box Hypothesis Validated by Research in New ZealandJuly 21st, 2005 A 30-year study of 1037 children has found that those who watch the most TV are least likely to go to university and get a degree. "Those who watched little television had the best chance of going on to university and earning a degree," said researcher Bob Hancox, deputy director of the Dunedin Research Unit.
Bird Flu Vaccine Developed by Indian ScientistsJuly 17th, 2006 Scientists of the Indian Council of Agricultural Research (ICAR) have succeeded in developing an indigenous vaccine against bird flu (H5N1 virus). This feat has been achieved by scientists working at the Bhopal-based High Security Animal Disease Laboratory (HSADL) in a record time of four months under a Rs 8-crore project.